Found: 123
Select item for more details and to access through your institution.
Phase separations in oncogenesis, tumor progressions and metastasis: a glance from hallmarks of cancer.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01522-5
- By:
- Publication type:
- Article
Integrative analysis of clinicopathological features defines novel prognostic models for mantle cell lymphoma in the immunochemotherapy era: a report from The North American Mantle Cell Lymphoma Consortium.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01520-7
- By:
- Publication type:
- Article
Harnessing immunotherapy for brain metastases: insights into tumor–brain microenvironment interactions and emerging treatment modalities.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01518-1
- By:
- Publication type:
- Article
Multiscale protein networks systematically identify aberrant protein interactions and oncogenic regulators in seven cancer types.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01517-2
- By:
- Publication type:
- Article
Safety and antitumor activity of metformin plus lanreotide in patients with advanced gastro-intestinal or lung neuroendocrine tumors: the phase Ib trial MetNET2.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01510-9
- By:
- Publication type:
- Article
Considerations for the design of antibody drug conjugates (ADCs) for clinical development: lessons learned.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01519-0
- By:
- Publication type:
- Article
Development and characterization of NILK-2301, a novel CEACAM5xCD3 κλ bispecific antibody for immunotherapy of CEACAM5-expressing cancers.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01516-3
- By:
- Publication type:
- Article
Reactive oxygen species (ROS) scavenging biomaterials for anti-inflammatory diseases: from mechanism to therapy.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01512-7
- By:
- Publication type:
- Article
Nanobody-based trispecific T cell engager (Nb-TriTE) enhances therapeutic efficacy by overcoming tumor-mediated immunosuppression.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01507-4
- By:
- Publication type:
- Article
Novel research and future prospects of artificial intelligence in cancer diagnosis and treatment.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01514-5
- By:
- Publication type:
- Article
Direct inhibition of dioxygenases TET1 by the rheumatoid arthritis drug auranofin selectively induces cancer cell death in T-ALL.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01513-6
- By:
- Publication type:
- Article
Genitourinary cancers updates: highlights from ASCO 2023.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01511-8
- By:
- Publication type:
- Article
Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01508-3
- By:
- Publication type:
- Article
Correction: Acylglycerol kinase promotes tumour growth and metastasis via activating the PI3K/AKT/GSK3β signalling pathway in renal cell carcinoma.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Retraction Note: The LINC00623/NAT10 signaling axis promotes pancreatic cancer progression by remodeling ac4C modification of mRNA.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Reprogramming T cell differentiation and exhaustion in CAR-T cell therapy.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01504-7
- By:
- Publication type:
- Article
CRISPR screening in hematology research: from bulk to single-cell level.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01495-5
- By:
- Publication type:
- Article
Correction: Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01503-8
- By:
- Publication type:
- Article
Correction: Non-T-depleted haploidentical transplantation with post-transplant cyclophosphamide in patients with secondary versus de novo AML in first complete remission: a study from the ALWP/EBMT.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Genomic profiling of post-transplant lymphoproliferative disorders using cell-free DNA.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01500-x
- By:
- Publication type:
- Article
Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01498-2
- By:
- Publication type:
- Article
CT041 CAR T cell therapy for Claudin18.2-positive metastatic pancreatic cancer.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01499-1
- By:
- Publication type:
- Article
Recent advances in targeted strategies for triple-negative breast cancer.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01497-3
- By:
- Publication type:
- Article
Beyond Bruton's tyrosine kinase inhibitors in mantle cell lymphoma: bispecific antibodies, antibody–drug conjugates, CAR T-cells, and novel agents.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01496-4
- By:
- Publication type:
- Article
Advances in single-cell RNA sequencing and its applications in cancer research.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01494-6
- By:
- Publication type:
- Article
Challenges and new technologies in adoptive cell therapy.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01492-8
- By:
- Publication type:
- Article
Phase I study evaluating the Fc-optimized FLT3 antibody FLYSYN in AML patients with measurable residual disease.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01490-w
- By:
- Publication type:
- Article
Retraction Note: HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Synergistic efficacy of simultaneous anti-TGF-β/VEGF bispecific antibody and PD-1 blockade in cancer therapy.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01487-5
- By:
- Publication type:
- Article
New immunotherapy strategies for patients with sarcomas: highlights from the 2023 ASCO annual meeting.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01486-6
- By:
- Publication type:
- Article
Novel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01480-y
- By:
- Publication type:
- Article
CD20 × CD3 bispecific antibodies for lymphoma therapy: latest updates from ASCO 2023 annual meeting.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01488-4
- By:
- Publication type:
- Article
Bispecific antibodies targeting BCMA, GPRC5D, and FcRH5 for multiple myeloma therapy: latest updates from ASCO 2023 Annual Meeting.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01489-3
- By:
- Publication type:
- Article
Methyltransferase-like proteins in cancer biology and potential therapeutic targeting.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01477-7
- By:
- Publication type:
- Article
Targeting NEDD8-activating enzyme for cancer therapy: developments, clinical trials, challenges and future research directions.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01485-7
- By:
- Publication type:
- Article
The CAR-HEMATOTOX score as a prognostic model of toxicity and response in patients receiving BCMA-directed CAR-T for relapsed/refractory multiple myeloma.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01465-x
- By:
- Publication type:
- Article
BCMA-targeted CAR-T cell therapies in relapsed and/or refractory multiple myeloma: latest updates from 2023 ASCO Annual Meeting.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01479-5
- By:
- Publication type:
- Article
Novel ADCs and combination therapy in urothelial carcinoma: latest updates from the 2023 ASCO-GU Cancers Symposium.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01475-9
- By:
- Publication type:
- Article
Hyperhomocysteinemia potentiates megakaryocyte differentiation and thrombopoiesis via GH-PI3K-Akt axis.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01481-x
- By:
- Publication type:
- Article
Bi- and trispecific immune cell engagers for immunotherapy of hematological malignancies.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01482-w
- By:
- Publication type:
- Article
Ten years of treatment with ruxolitinib for myelofibrosis: a review of safety.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01471-z
- By:
- Publication type:
- Article
Metabolism, metabolites, and macrophages in cancer.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01478-6
- By:
- Publication type:
- Article
Correction: Large-scale real-life analysis of survival and usage of therapies in multiple myeloma.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01484-8
- By:
- Publication type:
- Article
Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01470-0
- By:
- Publication type:
- Article
Novel target and treatment agents for natural killer/T-cell lymphoma.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01483-9
- By:
- Publication type:
- Article
GAS6-based CAR-T cells exhibit potent antitumor activity against pancreatic cancer.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01467-9
- By:
- Publication type:
- Article
Large-scale real-life analysis of survival and usage of therapies in multiple myeloma.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01474-w
- By:
- Publication type:
- Article
Clinical development of mRNA therapies against solid tumors.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01457-x
- By:
- Publication type:
- Article
Advances of medical nanorobots for future cancer treatments.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01463-z
- By:
- Publication type:
- Article